Group 1 - The core point of the article is that Chongde Technology (SZ 301548) held its 15th meeting of the second board of directors on October 22, 2025, via fax voting, discussing the proposal to amend relevant company systems [1] - For the first half of 2025, Chongde Technology's revenue composition is as follows: Industrial Drive accounted for 55.1%, Energy Generation 24.3%, Petrochemical 10.24%, Shipbuilding 6.06%, and Other Businesses 4.29% [1] - As of the report date, Chongde Technology has a market capitalization of 4.8 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have sold overseas licenses worth 80 billion USD this year, highlighting the hot secondary market in biomedicine [1] - A dialogue with Lu Gang, a partner at Chuangdong Investment, indicates that while the secondary market is thriving, fundraising in the primary market is facing challenges [1]
崇德科技：10月22日召开董事会会议